William Robert
Pediatrics · Grapevine, TXNPI 1588624506
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $563 and has fallen 74.6% since, to $143 in 2025. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $22.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$424
- Supernus Pharmaceuticals, Inc.$405
- Neos Therapeutics, LP$143
- Ironshore Pharmaceuticals Inc.$136
- Sanofi Pasteur Inc.$126
- Cranial Technologies, Inc$105
- plus $583 from 13 others
What the payments were for
- Food & beverage$1,921100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 17 | $424 |
| Supernus Pharmaceuticals, Inc. | 11 | $405 |
| Neos Therapeutics, LP | 7 | $143 |
| Ironshore Pharmaceuticals Inc. | 6 | $136 |
| Sanofi Pasteur Inc. | 6 | $126 |
| Cranial Technologies, Inc | 6 | $105 |
| Pfizer | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $81 |
| Corium, LLC | 4 | $80 |
| Merck | 4 | $60 |
| Arbor Pharmaceuticals, Inc. | 4 | $57 |
| Alk-abello, Inc | 2 | $49 |
| Genentech USA, Inc. | 2 | $38 |
| Immedica Pharma US, Inc. | 1 | $35 |
| Acadia Pharmaceuticals Inc | 1 | $29 |
| Seqirus USA Inc | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $15 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$247
How this compares
$1,921 in reported general payments places this provider in the 90th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Grapevine
- Michael McCoyGrapevine$9K
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
- Patricia AmersonSan Antonio$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.